[Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. III. Its use in some aspects of obstetric pathology].
D000028:Abortion, Induced; D000033:Abortion, Threatened / Q000188:drug therapy; D000328:Adult; D015232:Dinoprostone / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D005313:Fetal Death; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*
D011459:Prostaglandins E, Synthetic; C016767:sulprostone; D015232:Dinoprostone
Valutazioni clinico-sperimentali sull'uso del sulprostone, nuovo derivato PGE2. Nota III. Il suo impiego in alcuni aspetti di patologia ostetrica.